دورية أكاديمية
cCOG Web-Based Cognitive Assessment Tool.
| العنوان: | cCOG Web-Based Cognitive Assessment Tool. |
|---|---|
| المؤلفون: | Rhodius-Meester HFM; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands. h.rhodius@amsterdamumc.nl.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands. h.rhodius@amsterdamumc.nl.; Department of Internal medicine, Geriatric Medicine section, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands. h.rhodius@amsterdamumc.nl.; Department of Geriatric Medicine, The Memory Clinic, Oslo University Hospital, Oslo, Norway. h.rhodius@amsterdamumc.nl., Paajanen T; Work ability and Working Careers, Finnish Institute of Occupational Health, Helsinki, Finland., Lötjönen J; Combinostics Oy, Tampere, Finland. |
| المصدر: | Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2785, pp. 311-320. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Totowa, NJ : Humana Press Original Publication: Clifton, N.J. : Humana Press, |
| مواضيع طبية MeSH: | Cognitive Dysfunction*/diagnosis , Alzheimer Disease*/diagnosis, Humans ; Diagnosis, Differential ; Cognition ; Internet ; Biomarkers ; Disease Progression |
| مستخلص: | Cognitive testing is an essential part of clinical diagnostics and clinical trials in Alzheimer's disease. Digital cognitive tests hold a great opportunity to provide more versatile and cost-efficient patient pathways through flexible testing including at home. In this work, we describe a web-based cognitive test, cCOG, that can be used in screening, differential diagnosis, and monitoring the progression of neurodegenerative diseases. (© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.) |
| References: | Pouryamout L, Dams J, Wasem J, Dodel R, Neumann A (2012) Economic evaluation of treatment options in patients with Alzheimer’s disease: a systematic review of cost-effectiveness analyses. Drugs 72:789–802. (PMID: 10.2165/11631830-000000000-0000022480339) Lang L, Clifford A, Wei L, Zhang D, Leung D, Augustine G et al (2017) Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis. BMJ Open 7:e011146. (PMID: 10.1136/bmjopen-2016-011146281598455293981) van den Dungen P, van Marwijk HW, van der Horst HE, Moll van Charante EP, Macneil Vroomen J, van de Ven PM et al (2012) The accuracy of family physicians’ dementia diagnoses at different stages of dementia: a systematic review. Int J Geriatr Psychiatry 27:342–354. (PMID: 10.1002/gps.272621626568) Krolak-Salmon P, Maillet A, Vanacore N, Selbaek G, Rejdak K, Traykov L et al (2019) Toward a sequential strategy for diagnosing Neurocognitive disorders: a consensus from the “act on dementia” European joint action. J Alzheimers Dis 72:363–372. (PMID: 10.3233/JAD-19046131594224) de Wilde A, Ossenkoppele R, Pelkmans W, Bouwman F, Groot C, van Maurik I et al (2019) Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: the ABIDE project. Alzheimers Dement 15:1458–1467. (PMID: 10.1016/j.jalz.2019.07.00331594684) Lam J, Mattke S (2021) Memory care approaches to better leverage capacity of dementia specialists: a narrative synthesis. Neurodegenerative disease management 11:239–250. (PMID: 10.2217/nmt-2020-003833966489) Herring WL, Gould IG, Fillit H, Lindgren P, Forrestal F, Thompson R et al (2021) Predicted lifetime health outcomes for Aducanumab in patients with early Alzheimer’s disease. Neurology and therapy 10(2):919–940. (PMID: 10.1007/s40120-021-00273-0344269408571451) Getsios D, Blume S, Ishak KJ, Maclaine G, Hernandez L (2012) An economic evaluation of early assessment for Alzheimer’s disease in the United Kingdom. Alzheimers Dement 8:22–30. (PMID: 10.1016/j.jalz.2010.07.00121420366) van Maurik IS, Bakker ED, van den Buuse S, Gillissen F, van de Beek M, Lemstra E et al (2020) Psychosocial effects of Corona measures on patients with dementia, mild cognitive impairment and subjective cognitive decline. Front Psych 11:585686. (PMID: 10.3389/fpsyt.2020.585686) Lam J, Hlávka J, Mattke S (2019) The potential emergence of disease-modifying treatments for Alzheimer disease: the role of primary care in managing the patient journey. Journal of the American Board of Family Medicine: JABFM 32:931–940. (PMID: 10.3122/jabfm.2019.06.18032831704763) Tolonen AFM, Rhodius-Meester H, Bruun M, Koikkalainen J, Barkhof F, Lemstra A et al (2018) Data-driven differential diagnosis of dementia using multiclass disease state index classifier. Front Aging Neurosci 10:111. (PMID: 10.3389/fnagi.2018.00111299221455996907) Rhodius-Meester HFM, Paajanen T, Koikkalainen J, Mahdiani S, Bruun M, Baroni M et al (2020) cCOG: a web-based cognitive test tool for detecting neurodegenerative disorders. Alzheimers Dement (Amst) 12:e12083. (PMID: 32864411) van Gils AM, van de Beek M, van Unnik A, Tolonen A, Handgraaf D, van Leeuwenstijn M et al (2022) Optimizing cCOG, a web-based tool, to detect dementia with Lewy bodies. Alzheimers Dement (Amst) 14:e12379. (PMID: 10.1002/dad2.1237936569383) Tsoy E, Zygouris S, Possin KL (2021) Current state of self-administered brief computerized cognitive assessments for detection of cognitive disorders in older adults: a systematic review. J Prev Alzheimers Dis 8:267–276. (PMID: 341017837987552) Aslam RW, Bates V, Dundar Y, Hounsome J, Richardson M, Krishan A et al (2018) A systematic review of the diagnostic accuracy of automated tests for cognitive impairment. Int J Geriatr Psychiatry 33:561–575. (PMID: 10.1002/gps.4852293560985887872) van Gils A, van der Flier WM, Rhodius-Meester HFM (2021) Assessing the views of professionals, patients, and care partners concerning the use of computer tools in memory clinics: international survey study. J Med Internet Res 5:e31053. Wild K, Howieson D, Webbe F, Seelye A, Kaye J (2008) Status of computerized cognitive testing in aging: a systematic review. Alzheimers Dement 4:428–437. (PMID: 10.1016/j.jalz.2008.07.00319012868) Casaletto KB, Heaton RK (2017) Neuropsychological assessment: past and future. J Int Neuropsychol Soc 23:778–790. (PMID: 10.1017/S1355617717001060291982816296381) Bilder RM, Reise SP (2019) Neuropsychological tests of the future: how do we get there from here? Clin Neuropsychol 33:220–245. (PMID: 10.1080/13854046.2018.152199330422045) Mielke MM, Machulda MM, Hagen CE, Edwards KK, Roberts RO, Pankratz VS et al (2015) Performance of the CogState computerized battery in the Mayo Clinic Study on aging. Alzheimers Dement 11:1367–1376. (PMID: 10.1016/j.jalz.2015.01.00825858683) Mackin RS, Insel PS, Truran D, Finley S, Flenniken D, Nosheny R et al (2018) Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: results from the Brain Health Registry. Alzheimers Dement (Amst) 10:573–582. (PMID: 10.1016/j.dadm.2018.05.00530406176) Morrison GE, Simone CM, Ng NF, Hardy JL (2015) Reliability and validity of the NeuroCognitive Performance Test, a web-based neuropsychological assessment. Front Psychol 6:1652. (PMID: 10.3389/fpsyg.2015.01652265790354630791) Ruggeri K, Maguire A, Andrews JL, Martin E, Menon S (2016) Are we there yet? Exploring the impact of translating cognitive tests for dementia using mobile technology in an aging population. Front Aging Neurosci 8:21. (PMID: 10.3389/fnagi.2016.00021270140534794643) Wallace SE, Donoso Brown EV, Fairman AD, Beardshall K, Olexsovich A, Taylor A et al (2017) Validation of the standardized touchscreen assessment of cognition with neurotypical adults. NeuroRehabilitation 40:411–420. (PMID: 10.3233/NRE-16142828222561) Morrison RL, Pei H, Novak G, Kaufer DI, Welsh-Bohmer KA, Ruhmel S et al (2018) A computerized, self-administered test of verbal episodic memory in elderly patients with mild cognitive impairment and healthy participants: a randomized, crossover, validation study. Alzheimers Dement (Amst) 10:647–656. (PMID: 10.1016/j.dadm.2018.08.01030456291) |
| فهرسة مساهمة: | Keywords: Alzheimer’s disease; Cognitive testing; Digital biomarkers; Neurodegenerative diseases |
| المشرفين على المادة: | 0 (Biomarkers) |
| تواريخ الأحداث: | Date Created: 20240301 Date Completed: 20240304 Latest Revision: 20240506 |
| رمز التحديث: | 20240507 |
| DOI: | 10.1007/978-1-0716-3774-6_19 |
| PMID: | 38427202 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1940-6029 |
|---|---|
| DOI: | 10.1007/978-1-0716-3774-6_19 |